A multicenter, cross‐sectional analysis to assess the safety and usage pattern of brivaracetam in the management of partial‐onset seizure with BAEs—BREEZE study: A post‐hoc analysis

A multicenter, cross‐sectional analysis to assess the safety and usage pattern of brivaracetam in the management of partial‐onset seizure with BAEs—BREEZE study: A post‐hoc analysis

Abstract Objective Brivaracetam (BRV), a third‐generation anti‐seizure medication (ASM) offers strong conformational receptor domain binding, faster blood brain barrier (BBB) permeability and better tolerability making it potential therapeutic option as an initial line or initial line add‐on strateg...

Full description

Saved in:
Bibliographic Details
Main Authors: Arvind Sharma, Krishnaprasad Korukonda, Amit Haldar, Usha Kant Misra, R. V. Anand, Yakshdeep Dave, Girish Kulkarni
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Epilepsia Open
Subjects:
behavioral adverse event
epilepsy management
focal onset seizures
levetiracetam
monotherapy
Online Access:https://doi.org/10.1002/epi4.13065
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/epi4.13065

Similar Items